Roos RAC: Huntington’s disease: a clinical review. Orphanet J Rare Dis 2010,5(1):40.
Article
PubMed Central
PubMed
Google Scholar
Soulet D, Cicchetti F: The role of immunity in Huntington’s disease. Mol Psychiatry 2011,16(9):889–902.
Article
CAS
PubMed
Google Scholar
Aziz NA, Swaab DF, Pijl H, Roos RAC: Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington’s disease: clinical consequences and therapeutic implications. Rev Neurosci 2007,18(3–4):223–251.
CAS
PubMed
Google Scholar
Zuccato C, Valenza M, Cattaneo E: Molecular mechanisms and potential therapeutical targets in Huntington’s disease. Physiol Rev 2010,90(3):905–981.
Article
CAS
PubMed
Google Scholar
Kazantsev AG, Hersch SM: Drug targeting of dysregulated transcription in Huntington’s disease. Prog Neurobiol 2007,83(4):249–259.
Article
CAS
PubMed Central
PubMed
Google Scholar
Seredenina T, Luthi-Carter R: What have we learned from gene expression profiles in Huntington’s disease? Neurobiol Dis 2012,45(1):83–98.
Article
CAS
PubMed
Google Scholar
Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JHJ: Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 2008,28(42):10720–10733.
Article
CAS
PubMed Central
PubMed
Google Scholar
Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM: The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 2000,97(12):6763–6768.
Article
CAS
PubMed Central
PubMed
Google Scholar
Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR: Mouse models of Huntington disease: variations on a theme. Dis Model Mech 2009,2(3–4):123–129.
Article
CAS
PubMed Central
PubMed
Google Scholar
Ferrante RJ: Mouse models of Huntington’s disease and methodological considerations for therapeutic trials. Biochim Biophys Acta 2009,1792(6):506–520.
Article
CAS
PubMed Central
PubMed
Google Scholar
Crook ZR, Housman D: Huntington’s disease: can mice lead the way to treatment? Neuron 2011,69(3):423–435.
Article
CAS
PubMed
Google Scholar
Vonsattel JPG: Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008,115(1):55–69.
Article
PubMed Central
PubMed
Google Scholar
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies S, Bates G: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87: 493–506.
Article
CAS
PubMed
Google Scholar
Ribchester RR, Thomson D, Wood NI, Hinks T, Gillingwater TH, Wishart TM, Court FA, Morton AJ: Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington’s disease mutation. Eur J Neurosci 2004,20(11):3092–3114.
Article
PubMed
Google Scholar
Strand AD, Aragaki AK, Baquet ZC, Hodges A, Cunningham P, Holmans P, Jones KR, Jones L, Kooperberg C, Olson JM: Conservation of regional gene expression in mouse and human brain. PLoS Genet 2007,3(4):e59.
Article
PubMed Central
PubMed
CAS
Google Scholar
Diamanti D, Lahiri N, Tarditi A, Magnoni L, Fondelli C, Morena E, Malusa F, Pollio G, Diodato E, Tripepi G, Tabrizi SJ, Caricasole A, Mori E: Reference genes selection for transcriptional profiling in blood of HD patients and R6/2 mice. Journal of Huntington’s Disease 2013,2(2):185–200.
PubMed
Google Scholar
Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP: Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington’s disease. PLoS One 2009,4(11):e8025.
Article
PubMed Central
PubMed
CAS
Google Scholar
van der Burg JMM, Björkqvist M, Brundin P: Beyond the brain: widespread pathology in Huntington’s disease. Lancet Neurol 2009,8(8):765–774.
Article
PubMed
Google Scholar
Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, Möller T, Tabrizi SJ: A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med 2008,205(8):1869–1877.
Article
PubMed Central
PubMed
CAS
Google Scholar
Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D: Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease. Proc Natl Acad Sci U S A 2005,102(31):11023–11028.
Article
CAS
PubMed Central
PubMed
Google Scholar
Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, Régulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R: Analysis of potential transcriptomic biomarkers for Huntington’s disease in peripheral blood. Proc Natl Acad Sci U S A 2007,104(36):14424–14429.
Article
CAS
PubMed Central
PubMed
Google Scholar
Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E: Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington’s disease: restoration by the neuroprotective compound CEP-1347. Mol Cell Neurosci 2008,39(1):1–7.
Article
CAS
PubMed
Google Scholar
Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Björkqvist M, Petersén A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, Leavitt BR, Keir G, Ward M, Tabrizi SJ: Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 2007,6(7):2833–2840.
Article
CAS
PubMed
Google Scholar
Underwood BR, Broadhurst D, Dunn WB, Ellis DI, Michell AW, Vacher C, Mosedale DE, Kell DB, Barker RA, Grainger DJ, Rubinsztein DC: Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 2006,129(Pt 4):877–886.
Article
PubMed
Google Scholar
Carroll MV, Sim RB: Complement in health and disease. Adv Drug Deliv Rev 2011,63(12):965–975.
Article
CAS
PubMed
Google Scholar
Francis K, van Beek J, Canova C, Neal JW, Gasque P: Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med 2003,5(15):1–19.
Article
PubMed
Google Scholar
Nayak A, Ansar R, Verma SK, Bonifati DM, Kishore U: Huntington’s disease: an immune perspective. Neurol Res Int 2011, 2011: 563784.
Article
PubMed Central
PubMed
Google Scholar
Singhrao SK, Neal JW, Morgan BP, Gasque P: Increased complement biosynthesis by microglia and complement activation on neurons in Huntington’s disease. Exp Neurol 1999,159(2):362–376.
Article
CAS
PubMed
Google Scholar
Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, Björkqvist M: Abnormal peripheral chemokine profile in Huntington’s disease. PLoS Curr 2011., 3: RRN1231
Google Scholar
Wagner E, Frank MM: Therapeutic potential of complement modulation. Nat Rev Drug Discov 2010,9(1):43–56.
Article
CAS
PubMed
Google Scholar
Ricklin D, Lambris JD: Complement-targeted therapeutics. Nat Biotechnol 2007,25(11):1265–1275.
Article
CAS
PubMed Central
PubMed
Google Scholar
Kiaei M: Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington’s disease. PPAR Res 2008, 2008: 418765.
Article
PubMed Central
PubMed
CAS
Google Scholar
Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K: Adipose tissue dysfunction tracks disease progression in two Huntington’s disease mouse models. Hum Mol Genet 2009,18(6):1006–1016.
Article
CAS
PubMed Central
PubMed
Google Scholar
Valenza M, Cattaneo E: Emerging roles for cholesterol in Huntington’s disease. Trends Neurosci 2011,34(9):474–486.
Article
CAS
PubMed
Google Scholar
Valenza M, Cattaneo E: Cholesterol dysfunction in neurodegenerative diseases: is Huntington’s disease in the list? Prog Neurobiol 2006,80(4):165–176.
Article
CAS
PubMed
Google Scholar
Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I: Altered cholesterol and fatty acid metabolism in Huntington disease. J Clin Lipidol 2010,4(1):17–23.
Article
PubMed Central
PubMed
Google Scholar
Zündorf G, Reiser G: Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 2011,14(7):1275–1288.
Article
PubMed Central
PubMed
CAS
Google Scholar
Bezprozvanny I, Hayden MR: Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 2004,322(4):1310–1317.
Article
CAS
PubMed
Google Scholar
Jin YN, Johnson GVW: The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. Journal of bioenergetics and biomembranes 2010,42(3):199–205.
Article
CAS
PubMed Central
PubMed
Google Scholar
Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E: Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 2008,283(9):5780–5789.
Article
CAS
PubMed
Google Scholar
Damiano M, Galvan L, Déglon N, Brouillet E: Mitochondria in Huntington’s disease. Biochim Biophys Acta 2010,1802(1):52–61.
Article
CAS
PubMed
Google Scholar
Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL: Mitochondrial dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure. Journal of molecular and cellular cardiology 2001,33(6):1065–1089.
Article
CAS
PubMed
Google Scholar
Sorensen SA, Fenger K: Causes of death in patients with Huntington’s disease and in unaffected first degree relatives. Journal of medical genetics 1992,29(12):911–914.
Article
CAS
PubMed Central
PubMed
Google Scholar
Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter AT, Giussani DA, Morton AJ: Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington’s disease. Journal of Huntington’s Disease 2012,1(1):57–64.
Google Scholar
Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR: Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis 2007,25(2):297–308.
Article
CAS
PubMed Central
PubMed
Google Scholar
Aziz H, Zaas A, Ginsburg GS: Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Medicine 2007,1(3–4):105–112.
Article
PubMed Central
PubMed
Google Scholar
Mohr S, Liew CC: The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007,13(10):422–432.
Article
CAS
PubMed
Google Scholar
Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ: Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinforma 2003, 4: 26.
Article
Google Scholar
Larkin PB, Muchowski PJ: Genetic deficiency of complement component 3 does not alter disease progression in a mouse model of Huntington’s disease. J Huntingtons Dis 2012,1(1):107–118.
PubMed Central
PubMed
Google Scholar
She P, Zhang Z, Marchionini D, Diaz WC, Jetton TJ, Kimball SR, Vary TC, Lang CH, Lynch CJ: Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington’s disease. Am J Physiol Endocrinol Metab 2011,301(1):E49-E61.
Article
CAS
PubMed Central
PubMed
Google Scholar
Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM: Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 2002,11(17):1911–1926.
Article
CAS
PubMed
Google Scholar
Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM: Gene expression in Huntington’s disease skeletal muscle: a potential biomarker. Hum Mol Genet 2005,14(13):1863–1876.
Article
CAS
PubMed
Google Scholar
Greco 3J, Pollins AC, Boone BE, Levy SE, Nanney LB: A microarray analysis of temporal gene expression profiles in thermally injured human skin. Burns 2010,36(2):192–204.
Article
PubMed Central
PubMed
Google Scholar
Zabel C, Chamrad DC, Priller J, Woodman B, Meyer HE, Bates GP, Klose J: Alterations in the mouse and human proteome caused by Huntington’s disease. Mol Cell Proteomics 2002,1(5):366–375.
Article
CAS
PubMed
Google Scholar
Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RLM, Olson JM, Jones L, Luthi-Carter R: Regional and cellular gene expression changes in human Huntington’s disease brain. Hum Mol Genet 2006,15(6):965–977.
Article
CAS
PubMed
Google Scholar
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004,5(10):R80.
Article
PubMed Central
PubMed
Google Scholar
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of affymetrix genechip probe level data. Nucleic Acids Res 2003,31(4):e15.
Article
PubMed Central
PubMed
CAS
Google Scholar
Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003,19(2):185–193.
Article
CAS
PubMed
Google Scholar
Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004., 3: article 3
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005,102(43):15545–15550.
Article
CAS
PubMed Central
PubMed
Google Scholar
Luo W, Brouwer C: Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 2013,29(14):1830–1831.
Article
CAS
PubMed Central
PubMed
Google Scholar